0001562180-16-003298.txt : 20161031
0001562180-16-003298.hdr.sgml : 20161031
20161031191523
ACCESSION NUMBER: 0001562180-16-003298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161027
FILED AS OF DATE: 20161031
DATE AS OF CHANGE: 20161031
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Orwin John A
CENTRAL INDEX KEY: 0001477384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 161962917
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-10-27
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001477384
Orwin John A
C/O RELYPSA, INC.
700 SAGINAW DR.
REDWOOD CITY
CA
94063
true
false
false
false
Common Stock
2016-10-29
4
M
false
5000.00
5.83
A
5000.00
D
Restricted Stock Units
0.00
2016-10-27
4
A
false
5000.00
0.00
A
2017-10-27
Common Stock
5000.00
5000.00
D
Stock Option (Right to Buy)
5.95
2016-10-27
4
A
false
25000.00
0.00
A
2017-10-27
2026-10-27
Common Stock
25000.00
25000.00
D
Restricted Stock Units
0.00
2016-10-29
4
M
false
5000.00
0.00
D
2016-10-29
Common Stock
5000.00
0.00
D
Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on October 29, 2015 as a results of the vesting of all such RSUs.
RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vest and will be settled in stock on October 27, 2017, subject to continued service on Array's board of directors.
RSUs awarded to the reporting person on October 29, 2015 for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vested and were settled in stock on October 29, 2016.
John R. Moore, attorney-in-fact for Reporting Person
2016-10-31